These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22228721)

  • 1. Ignoring evidence has led to ineffective drug policies, shows research.
    Mooney H
    BMJ; 2012 Jan; 344():e148. PubMed ID: 22228721
    [No Abstract]   [Full Text] [Related]  

  • 2. How do drug policy makers access research evidence?
    Ritter A
    Int J Drug Policy; 2009 Jan; 20(1):70-5. PubMed ID: 18226519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What would evidence-informed drug policies look like?
    Hall W
    Addiction; 2010 Jul; 105(7):1135-6. PubMed ID: 20642497
    [No Abstract]   [Full Text] [Related]  

  • 4. Physician Leadership on National Drug Policy: advocacy for an effective drug policy.
    Lewis DC
    Med Health R I; 1999 Mar; 82(3):101-4. PubMed ID: 10193141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug policy: let's maintain pressure on regulatory authorities.
    Prescrire Int; 2013 Apr; 22(137):107. PubMed ID: 23662324
    [No Abstract]   [Full Text] [Related]  

  • 6. Lethal drug abuse act fails this session.
    Hosp Outlook; 1998 Oct; 1(9):1-2. PubMed ID: 10187189
    [No Abstract]   [Full Text] [Related]  

  • 7. A tale of CIN--the Cannabis infringement notice scheme in Western Australia.
    Lenton S; Allsop S
    Addiction; 2010 May; 105(5):808-16. PubMed ID: 20331566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What would an evidence based drug policy be like?
    Singleton N; Strang J
    BMJ; 2014 Dec; 349():g7493. PubMed ID: 25492041
    [No Abstract]   [Full Text] [Related]  

  • 9. The contribution of research to Australian policy responses to heroin dependence 1990-2001: a personal retrospection.
    Hall W
    Addiction; 2004 May; 99(5):560-9. PubMed ID: 15078230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based policy or policy-based evidence? The role of evidence in the development and implementation of the Illicit Drug Diversion Initiative.
    Hughes CE
    Drug Alcohol Rev; 2007 Jul; 26(4):363-8. PubMed ID: 17564871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Anabolic Steroid Control Act of 2004: a study in the political economy of drug policy.
    Denham BE
    J Health Soc Policy; 2006; 22(2):51-78. PubMed ID: 17255072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US Public Health Agency involvement in youth-focused illicit drug policy, planning, and prevention at the local level, 1999-2003.
    McBride DC; Terry-McElrath YM; VanderWaal CJ; Chriqui JF; Myllyluoma J
    Am J Public Health; 2008 Feb; 98(2):270-7. PubMed ID: 18172140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenges in developing a rational cannabis policy.
    Hall W; Lynskey M
    Curr Opin Psychiatry; 2009 May; 22(3):258-62. PubMed ID: 19293714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving state pain policies: recent progress and continuing opportunities.
    Gilson AM; Joranson DE; Maurer MA
    CA Cancer J Clin; 2007; 57(6):341-53. PubMed ID: 17989129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of policy: understanding the process of policy development.
    Ryder D
    Addiction; 1996 Sep; 91(9):1265-70. PubMed ID: 8854357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Political and legal institutions and their influence on drug policy: an Australian perspective.
    Ryder D
    Drug Alcohol Rev; 2008 Jul; 27(4):374-9. PubMed ID: 18584386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Too high in California?
    Shannon E
    Time; 1997 Dec; 150(24):84. PubMed ID: 10182525
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program.
    Ritter A; Bammer G; Hamilton M; Mazerolle L;
    Drug Alcohol Rev; 2007 May; 26(3):265-71. PubMed ID: 17454015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balance, change, and responsible prescribing: clinicians need updated regulatory policies and the tools to evaluate patients and meet clinical and regulatory obligations!
    Bolen J
    Clin J Pain; 2010 Jan; 26(1):78-9. PubMed ID: 20026958
    [No Abstract]   [Full Text] [Related]  

  • 20. Implication for research of the 1988 Anti-Drug Abuse Act.
    Schuster CR
    NIDA Res Monogr; 1989; 95():16-22. PubMed ID: 2640964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.